Actinomycin D effects on nucleic acids during tumor regression.
D000818:Animals; D001365:Axilla; D002247:Carbon Isotopes; D003124:Colorimetry; D004247:DNA / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000378:metabolism*; D003609:Dactinomycin / Q000627:therapeutic use*; D005260:Female; D007421:Intestine, Small / Q000378:metabolism; D051379:Mice; D009363:Neoplasm Proteins / Q000378:metabolism; D009368:Neoplasm Transplantation; D012516:Osteosarcoma / Q000188:drug therapy* / Q000378:metabolism; D010759:Phosphorus Isotopes; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism*; D012334:RNA, Neoplasm / Q000378:metabolism*; D012513:Sarcoma, Experimental / Q000188:drug therapy* / Q000378:metabolism; D013936:Thymidine; D014529:Uridine
D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D010759:Phosphorus Isotopes; D011506:Proteins; D012334:RNA, Neoplasm; D003609:Dactinomycin; D012313:RNA; D004247:DNA; D013936:Thymidine; D014529:Uridine